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A B S T R A C T
Purpose: To report the frequency and predictors of presenting seizures in cerebral venous sinus
thrombosis (CVST) and their inﬂuence on seizure recurrence and outcome.
Methods: This retrospective study, between 1995 and 2011, included 90 consecutive patients with CVST
diagnosed using magnetic resonance imaging (MRI) and magnetic resonance venography (MRV). Clinical
parameters like frequency, type (presenting, early, and late), and duration of seizures, precipitating
causes of CVST, and underlying prothrombotic conditions, were recorded. The location of infarction on
MRI and the number of sinuses involved on MRV, were noted. The patients were prescribed
anticoagulants, and those with seizures were prescribed antiepileptic drugs. The patients were followed
up at 3, 6, and 12 months. The functional outcome at 6 months was categorized into death, poor, partial
and complete recovery.
Results: A total of 42 patients with CVST presented with seizures (focal 11, focal with secondary generalized
19, and generalized tonic clonic 16), of whom 10 had status epilepticus. On univariate analysis,
supratentorial lesion (P = 0.005), frontal (P = 0.02) or parietal lobe (P = 0.04) involvement and haemorrhagic
lesion (P = 0.002) were associated with higher risk of presenting seizure. On multivariate analysis, only
supratentorial parenchymal lesion on MRI (odds ratio [OR] = 4.67, 95% conﬁdence interval [CI] 1.51–15.08,
P = 0.005) was independently associated with higher risk of presenting seizure. Only 4 patients had early
seizures and none had late seizures. At 6 months, 10 patients died and 73 patients had complete recovery.
Seizures were not associated with death (P = 1.00) and 6-month functional outcome (P = 0.66).
Conclusion: About half the patients with CVST had presenting seizures which was independently related
to supratentorial lesion. However, seizures were not related to death or 6-month outcome.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Seizures are the presenting feature of cerebral venous sinus
thrombosis (CVST) in 12–31.9% of patients, while up to 44.3% of
patients may have seizures in the early stage of the disease.1,2 The
patients with sensory motor deﬁcit, cortical vein thrombosis and
supratentorial lesion, on computerized tomography (CT) or
magnetic resonance imaging (MRI), are more likely to have seizure
compared to those without these conditions.1–3 Seizures may
adversely affect the prognosis, especially in patients with raised
intracranial pressure. In a recent study on CVST, mortality in
patients with seizures was three times higher than in those
without seizures.2 In a case controlled study, antiepileptic drugs
(AEDs) reduced the occurrence of early seizures in the patients
with supratentorial lesion on CT or MRI.1
Although CVST is common in India, there is no comprehensive
study evaluating the predictors of seizures and their inﬂuence on* Corresponding author at: Department of Neurology, Sanjay Gandhi Postgradu-
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Portugal.1 There is no information on the occurrence of late
seizures in Indian CVST patients and their response to AED. In the
present communication, we report the predictors of presenting
seizures in patients with CVST and their inﬂuence on outcome and
occurrence of late seizures.
2. Subjects and methods
2.1. Subjects
Between 1995 and 2011, consecutive patients with CVST were
retrospectively analysed and data were collected from a prospec-
tively maintained CVST registry. The patients with past history of
seizure, mental retardation, febrile convulsion, and associated
structural lesion other than CVST were excluded.
2.2. Data collection
A detailed medical history including deep vein thrombosis,
spontaneous abortion, oral contraceptive, pregnancy, infection,
dehydration, malignancy, and family history of venous thrombosisvier Ltd. All rights reserved.
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were recorded. The presence of seizure, its type, duration, and
frequency were noted. Status epilepticus was deﬁned if the seizure
lasted for more than 10 min. The seizures were categorized into
presenting seizure (before the diagnosis of CVST), early seizure
(within 14 days of diagnosis of CVST), and late seizure (after
14 days of diagnosis of CVST).
Consciousness was assessed by Glasgow Coma Scale (GCS). The
presence of cranial nerve palsy and papilloedema were noted. The
muscle power was graded on a 0–5 Medical Research Council
(MRC) scale, and muscle tone and tendon reﬂexes were also
recorded. Co-ordination and sensation were tested in patients who
could co-operate. The patients were investigated for underlying
prothrombotic conditions and aetiology of CVST.
On MRI, the presence of supratentorial parenchymal lesions,
their location (frontal, parietal, temporal or occipital) and type (pale
or haemorrhagic infarction) were noted. On MRV, the location and
extent of thrombosis and the number of sinuses affected were noted.
The direct evidences of cerebral vein and sinus thrombosis on MRI
were also considered in the diagnosis of CVST.
2.3. Treatment
Patients were treated with low molecular weight heparin or
unfractionated heparin for 14 days followed by oral anticoagulant,
and their International Normalized Ratio (INR) was maintained
between 2 and 3. Patients with seizure were treated with AED, and
those with status epilepticus were treated with intravenous
lorazepam.
2.4. Outcome
Occurrence of early and late seizures was noted and recurrence
of seizure was also recorded. The hospital mortality and its causes
were recorded. Patients were followed up at 3, 6 and 12 months
and their seizures and functional outcome were noted. The
functional outcome was categorized on the basis of Barthel Index
(BI) score into poor (BI < 12), partial (BI = 13–19), and complete
(BI = 20) recovery.4 BI was used for assessing the functional
outcome as it evaluates 10 domains of activities of daily living
which include feeding, grooming, bowel, bladder, bed to chair
transfer, dressing, mobility, bathing, toilet, and climbing stairs.
2.5. Statistical analysis
The baseline characteristics of the patients with and without
presenting seizure were compared by Chi square or independent t
test. The predictors of presenting seizure were evaluated by
univariate analysis including the demographic (gender, age),
clinical (headache, vomiting, focal neurological deﬁcit, papilloe-
dema, GCS score), aetiology, number of risk factors, MRI ﬁndings
(supratentorial lesion, location of lesion, haemorrhagic vs. non-
haemorrhagic infarction), and MRV ﬁndings (superﬁcial or deep
sinus, cortical veins and number of sinuses involved). The variables
having a two tailed P-value of <0.10 on univariate analysis were
included in the multivariate analysis. The patients who left
hospital due to deteriorating clinical conditions were included in
death group in the statistical analysis. At 6 months, the patients
who died in hospital or during the follow-up and those lost to
follow-up were included in the poor recovery group in the
statistical analysis. The relationships of death and 6-month
outcomes with presenting seizure were evaluated by Chi square
test with Yates correction. The statistical analysis was done using
SPSS for Windows version 16.0 (SPSS, Chicago, IL, USA) or Epi-Info
version 6.04 (CDC, Atlanta, GA, USA) and the variable was
considered signiﬁcant if the two-tailed P-value was 0.05.3. Results
Our results are based on 90 patients with CVST whose median
age was 30 (range: 6–76) years and 48 (53.3%) patients were
females. A total of 42 (46.7%) patients had presenting seizure and 4
(4.4%) had early seizure. The seizures were categorized as focal
(n = 11), focal with secondary generalized (n = 19), and generalized
tonic clonic (n = 16). There were 10 patients with generalized
convulsive status epilepticus, and the remaining (n = 36) had
discrete seizure with a frequency of seizure ranging between 1 and
4. Cranial MRI revealed infarction in 63 (70%) patients of which 45
patients had haemorrhagic changes. MRV revealed involvement of
superﬁcial sinuses (n = 77); deep sinuses (n = 5), and both (n = 8).
Cortical vein thrombosis was noted in 4 patients.
3.1. Predictors of seizure
According to the univariate analysis, vomiting was signiﬁcantly
related to presenting seizure (P = 0.04). Age (P = 0.70), gender
(P = 0.97), duration of illness (P = 0.13), headache (P = 1.0),
papilloedema (P = 0.1), GCS score <9 (P = 0.99), underlying
aetiology (P = 0.17), focal neurological deﬁcit (P = 0.06), and death
(P = 1.0) were not related to presenting seizure. The supratentorial
parenchymal lesion (P = 0.005), haemorrhagic infarction
(P = 0.002) and frontal lobe (P = .0.02) and parietal (P = 0.04) lobe
involvement on MRI were signiﬁcantly related to presenting
seizure but the site of thrombosis and number of sinuses involved
were not. The details are summarized in Table 1. On multivariate
analysis, the supratentorial parenchymal lesion on MRI (odds ratio
[OR] = 4.67, 95% conﬁdence interval [CI] 1.51–15.08, P = 0.005) was
independently associated with presenting seizure. It was observed
that the frequency of seizure recurrence during hospital stay
(21/42, 50%) was higher in patients with presenting seizure than in
patients with early seizure (1/4, 25%, P = 0.61).
Among patients with presenting or early seizure (n = 46), 4
patients died in the hospital, while among patients without
seizures (n = 44), 2 patients died. Three patients (one with and two
without seizure) left hospital due to deteriorating clinical
conditions and they were included in death group in the statistical
analysis. One patient died after hospital discharge. Death was not
related to presenting seizure (P = 1.00) or early seizure (P = 1.00).
None of the patients with status epilepticus died (P = 0.58). At
3 months, the survivors showed complete (n = 71), partial (n = 3)
and poor (n = 6) recovery, while one patient was lost to follow-up.
At 6 months, only 6 patients had poor and the remaining had
complete recovery, and one patient was lost to follow-up (Table 2).
The outcome at 6 months was also not different in the patients
with presenting or early seizure compared to those without
(P = 0.79).
During the 12 month follow-up, 5 patients had recurrent
seizures; of these, 4 patients had been earlier diagnosed with
presenting seizure and one patient with early seizure; no patient
had late seizure. In one patient, seizure recurrence was due to drug
default. Of these 5 patients, 4 had supratentorial lesion. The
location of parenchymal lesion was not signiﬁcantly different in
the patients with and without late recurrence of seizure.
4. Discussion
In this retrospective analysis, 46.7% patients with CVST had
presenting seizure, 4.4% had early seizure and none had late
seizure; but, 5.6% had late recurrence of seizure. The frequency of
seizures was signiﬁcantly higher in the patients with supratentor-
ial lesion, especially with the haemorrhagic lesion in frontoparietal
region. Seizures in CVST are more commonly reported in neonates
(71%) and children (48%), as compared to adults (37%).5,6 In our
Table 1





OR 95% CI P-value
Female 22 26 0.93 0.37–2.32 0.97
Headache 39 44 1.18 0.21–7.19 1.00
Focal deﬁcit 26 19 2.48 0.98–6.37 0.06
GCS (<9) 8 8 1.18 0.35–3.93 0.99
Papilloedema 9 19 0.42 0.15–1.16 0.10
Risk factors 35 33 2.27 0.75–7.11 0.17
Number of risk factors
2 27 27 1.4 0.55–3.58 0.58
>2 8 6 1.65 0.46–6.02 0.57
None 7 15 0.44 0.14–1.34 0.17
Deatha 5 5 1.16 0.26–5.12 1.00
Supratentorial/parenchymal lesion 36 27 4.67 1.51–15.08 0.005
Bilateral cerebral lesion 10 9 1.35 0.44–4.19 0.74
Cortical vein thrombosis 3 1 3.62 0.31–94.04 0.34
Types of stroke
Ischaemic 7 11 0.67 0.21–2.16 0.63
Haemorrhagic 29 16 4.46 1.68–12.03 0.002
Location
Frontal 18 9 3.25 1.15–9.39 0.02
Parietal 21 13 2.69 1.03–7.15 0.04
Temporal 9 5 2.35 0.64–9.01 0.25
Occipital 10 10 1.19 0.39–3.59 0.93
Abbreviations: CI, conﬁdence interval; GCS, Glasgow Coma Scale; MRI, magnetic resonance imaging; OR, odds ratio.
a Includes patients who left due to deteriorating clinical conditions (1 with presenting seizure and 2 without seizures).
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fewer children in this cohort. The clinical variables and the
aetiology of CVST were also not related to presenting seizure. An
earlier study, however, reported sensory motor deﬁcit, aphasia and
depth of coma, as predictors of seizure.2
In the present study, the supratentorial lesion was associated
with more than 4.67 times higher risk of seizure. This is in
agreement with a multicentre study of CVST in which supraten-
torial lesion was associated with 4.92 times higher risk of
presenting seizure. However, the signiﬁcance of involvement of
different cerebral regions was not reported.7 In our study, though
frontal and parietal lobe lesions were associated with signiﬁcantly
higher risk of presenting seizure by univariate analysis. Bousser
and Russel reported that seizures are more frequent if the lesions
are located anterior to the central sulcus and in patients with focal
deﬁcit.8 The mechanism of seizure in haemorrhagic lesion is not
well understood. Blood metabolites such as haemosiderin may
cause focal cerebral irritation leading to seizure as reported in
traumatic brain injury and animal experiment.9,10 In a recent
report, the risk of acute symptomatic seizure was 2.7 times higher
in haemorrhagic infarction compared to pale infarction. Total
anterior circulation infarctions carried the highest risk of seizure
(10.7%) compared to posterior circulation infarction (4.7%).
Mortality rate observed in patients with seizure (12.5%) wasTable 2
Six-month outcomes in patients having cerebral venous sinus thrombosis with or
without presenting/early seizures.





Deaths within 15 daysa 5 4 1.00
6-Month outcomes,
n (%)
Complete 36 (78.3) 37 (86.4) 0.66
Poorb 10 (21.7) 7 (13.6)
a Include deaths during hospitalization (n = 6) and patients who left hospital due
to deteriorating clinical condition (n = 3).
b Includes deaths during hospitalization (n = 6); deaths after hospital discharge
(n = 1); patients who left hospital due to deteriorating clinical condition (n = 3),
dependency (n = 6), and lost to follow-up (n = 1). CVST, cerebral venous sinus
thrombosis.higher than that observed in patients without seizure (6.3%).11 A
multicentre study on CVST also revealed higher deaths and
dependency in the patients with seizure (26%) compared to those
without seizure (14.8%).7 In our study, however, death was not
related to presenting seizure. This difference may be due to smaller
sample size, difference in patient population, and tertiary care
single centre study with uniform treatment protocol used in our
study.
The higher frequency of seizure has been reported in the
patients with straight sinus or cerebral vein thrombosis.7 In our
study, the majority of patients (56.6%) had more than one sinus
involvement and presenting seizure was not related to number of
sinuses involved, as well as to the location of thrombosis.
In this study, no patient had late seizure although seizure
recurred in 5 patients who had either presenting (4 patients) or
early seizure (1 patient). All our patients with presenting and early
seizures received AEDs and none without seizures were on AED. In
a study, 9.5% of patients had late seizure, especially those with
early symptomatic seizure, and haemorrhagic lesions on CT or
MRI.12 In our study, only 5.6% of patients had late recurrence of
seizure and it was not related to location of MRI lesion. The lower
frequency of late recurrence of seizure in our study may be due to
the use of AED in all the patients who had presenting or early
seizures, whereas in an earlier study, 10% of patients did not
receive AED in spite of having early seizures.12 In our study,
presenting and early seizures were not related to the late
recurrences although a previous study have reported the correla-
tion of early seizure with the late recurrences.12 The 6-month
outcome of our patients was not related to presenting or early
seizures. All the patients with status epilepticus also survived.
These results are in agreement with the International Study on
Cerebral Vein and Dural Sinus Thrombosis cohort, in whom seizure
was not an independent predictor of death or dependency.13
5. Conclusion
About half the patients with CVST had either presenting or early
seizures. The patients with haemorrhagic supratentorial lesion
involving the frontoparietal region are more likely to have seizure.
J. Kalita et al. / Seizure 21 (2012) 639–642642The presence of seizure, however, is not a predictor of death or
disability at 6 months.
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